Earnings Feed
Start Free
G1 Therapeutics, Inc.·4

Feb 2, 5:20 PM ET

Moses Jennifer K. 4

4 · G1 Therapeutics, Inc. · Filed Feb 2, 2022

Insider Transaction Report

Form 4
Period: 2022-02-01
G1 Therapeutics, Inc.GTHX
Moses Jennifer K.
VP of Finance & Admin
Transactions
  • Exercise/Conversion

    Common Stock

    2022-02-01$4.17/sh+2,000$8,340→ 37,888 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-02-01−2,000→ 58,000 total
    Exercise: $4.17Exp: 2026-05-10→ Common Stock (2,000 underlying)
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2022-02-01−333→ 0 total
    Exercise: $3.72Exp: 2025-12-21→ Common Stock (333 underlying)
  • Exercise/Conversion

    Common Stock

    2022-02-01$3.72/sh+333$1,239→ 35,888 total
Footnotes (3)
  • [F1]Represents (i) 15,638 shares of common stock; (ii) 8,250 RSUs from award granted on January 4, 2021; and (iii) 12,000 RSUs from award granted on January 3, 2022.
  • [F2]Represents (i) 17,638 shares of common stock; (ii) 8,250 RSUs from award granted on January 4, 2021; and (iii) 12,000 RSUs from award granted on January 3, 2022.
  • [F3]All shares underlying this option have vested.

Documents

2 files